Category Archives: HIV/AIDS

Survey across seven African countries finds young women and teenage girls less than halfway to 2020 goals for HIV control

By on .

Fewer than half of the adolescent girls and young women living with HIV who were tested for the virus as part of door-to-door surveys across communities in seven African countries were already aware of their infection, according to findings released by the U.S. Centers for Disease Control and Prevention. That’s far short of the 2020 […]

In Guatemala study, illnesses indicating AIDS were already present in about fourth of patients newly diagnosed with HIV

By on .

At Guatemala’s largest HIV clinic, researchers took a retrospective study of current patient records. One in four patients, they found, had an illness indicating advanced progression of the virus at the time they were diagnosed, increasing their risks of other diseases and death, while increasing the costs of their care. With plans now turning to […]

Keeping the balance in how we prevent HIV: Evaluating structural interventions

By on .

The following is a guest post by Jim Thomas, PhD In 1978, the world celebrated the end of smallpox. Through a coordinated multinational effort, a global vaccination program had reached the furthest corners of the earth and eliminated the ability of the virus to spread. The success was intoxicating. Lists of the next diseases to […]

Analysis highlights role of diplomacy in U.S. HIV response leadership, PEPFAR gains

By on .

Conceived as an urgent response to a global health crisis with national security ramifications, the design of the U.S. President’s Emergency Plan for AIDS Relief as a historically ambitious attack on a single disease was unique from the start. In recognition of economic and political factors that had hampered responses to the pandemic at home […]

Analysis: Trump PEPFAR strategy, budget proposals add up to surrender in HIV battle

By on .

White House proposals to slash more than a billion dollars from U.S. supported HIV responses and limit efforts to control the epidemic to a handful of countries represents an unprecedented retreat from American leadership of the global fight against the disease and would reverse gains that were achieved, at a cost of more than $80 […]

Medical circumcision efforts gained ground against new HIV infections, but not enough

By on .

Focused efforts to protect men and boys from HIV led to more than 14.5 million medical circumcision procedures globally between 2008 and 2016, enough to avert an estimated half million infections by 2030, according to a report released today. That progress, however, falls at least 30 percent short of the nearly 21 million procedures originally […]

For people with HIV, viral suppression is critical to protection from yellow fever vaccine

By on .

A study on the effectiveness of the yellow fever vaccine among people living with HIV yields yet another reason that universal access to effective consistent antiretroviral medicine for people with the virus is important to global public health. The study, published in the recent Clinical Infectious Diseases found that the yellow fever vaccine offers long-term […]

IDWeek presenter highlights global implications of HIV treatment resistance in Philippines

By on .

Oct. 7, 2017 SAN DIEGO –  Dr. Edsel Salvaña has two posters in the exhibit hall here, each one carrying terrible news from the Philippines, that, if you pause to look at the one he stands in front of, he will cheerfully and concisely explain, has frightening implications well beyond his country. In fact, with […]

What we’re reading: Treatment is prevention, TB is a priority, welcome words and more

By on .

“This means that people who take ART daily as prescribed . . . and achieve and maintain an undetectable viral load have effectively no risk of sexually transmitting the virus to an HIV-negative partner . . .” With these words the U.S. Centers for Disease Control and Prevention effectively put on the record a truth […]

PrEP presents questions for HIV prevention researchers, survey seeks answers

By on .

The trial to determine the effectiveness of a vaccine against HIV that was known as HVTN 505 was underway in 2010 when results from another, wholly unrelated trial presented a challenge. Those results, from the iPrEx trial, showed that an antiretroviral drug taken as pre-exposure prophylaxis — or PrEP — was effective in protecting uninfected […]